, 20 mg/0.4 mL and 10 mg/0.2 mL pre-filled syringe and as a 40 mg/0.8 mL pre-filled autoinjector called the Cyltezo Pen. Express Scripts is the pharmacy benefits management business of The Cigna Group’s Evernorth℠. Coverage for eligible patients is effective as of July 12, 2023....
Express Scriptspicked 15 programs from hundreds of submissions to include in its first release starting in January, 2020. They were evaluated based on three criteria: clinical research, usability and financial value. The selected solutions address a wide variety of common chronic health condit...
The article focuses on the addition of the cholesterol-lowering drugs such as PCSK9 inhibitors Praluent and Repatha to the National Preferred Formulary of Express Scripts, a pharmacy benefit management organization.doi:10.1007/s40274-015-2548-1None...
Express Scripts Holding Co.(NASDAQ:ESRX) announced its 2019National Preferred Formulary Exclusions, noting that the exclusions were driven not only by the size of the rebate as in years past, but also by lower list prices, garnering HCV drug Zepatier grazoprevir/elbasvir co-exclusive status....
“The solution will help Express Scripts execute on its mission of creating a better healthcare system by providing greater choice, predictability, affordability and improved outcomes,” SilverCloud CEO Ken Cahill said in a news release. “It also adds another effective tool for the company to uti...
Express Scripts may switch hepatitis C drugs on preferred formularyWhile pharmaceutical manufacturer AbbVie's new hepatitis C drug has not yet been approved by FDA, pharmacy benefits manager Express Scripts has expressed interest in switching to the drug in its preferred drug formula...
Express Scripts and AbbVie Ink Landmark Formulary Exclusivity DealRandi Hernandez
Cathy Kelly
How Express Scripts will manage pricey cholesterol drugsChristine BlankContributing Editor